Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Hippo pathway inhibition induces regeneration of retinal pigment epithelium
Author Affiliations & Notes
  • Erik Arthur Souverein
    Keck School of Medicine of University of Southern California, Los Angeles, California, United States
    The Vision Center, Children's Hospital Los Angeles, Los Angeles, California, United States
  • Zachary Fouladian
    Keck School of Medicine of University of Southern California, Los Angeles, California, United States
    The Vision Center, Children's Hospital Los Angeles, Los Angeles, California, United States
  • Mark Reid
    The Vision Center, Children's Hospital Los Angeles, Los Angeles, California, United States
  • G. Esteban Fernandez
    The Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, California, United States
  • Andrew Salas
    The Vision Center, Children's Hospital Los Angeles, Los Angeles, California, United States
    The Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, California, United States
  • Sushma Kalmodia
    The Vision Center, Children's Hospital Los Angeles, Los Angeles, California, United States
  • Jennifer Aparicio
    The Vision Center, Children's Hospital Los Angeles, Los Angeles, California, United States
  • A. James Hudspeth
    Howard Hughes Medical Institute and Laboratory of Sensory Neuroscience, The Rockefeller University, New York, New York, United States
  • Ksenia Gnedeva
    Tina and Rick Caruso Department of Otolaryngology-Head and Neck Surgery, Keck School of Medicine of University of Southern California, Los Angeles, California, United States
  • Aaron Nagiel
    Keck School of Medicine of University of Southern California, Los Angeles, California, United States
    The Vision Center, Children's Hospital Los Angeles, Los Angeles, California, United States
  • Footnotes
    Commercial Relationships   Erik Souverein None; Zachary Fouladian None; Mark Reid None; G. Esteban Fernandez None; Andrew Salas None; Sushma Kalmodia None; Jennifer Aparicio None; A. James Hudspeth None; Ksenia Gnedeva None; Aaron Nagiel None
  • Footnotes
    Support  Edward N. and Della L. Thome Memorial Foundation
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 6143. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Erik Arthur Souverein, Zachary Fouladian, Mark Reid, G. Esteban Fernandez, Andrew Salas, Sushma Kalmodia, Jennifer Aparicio, A. James Hudspeth, Ksenia Gnedeva, Aaron Nagiel; Hippo pathway inhibition induces regeneration of retinal pigment epithelium. Invest. Ophthalmol. Vis. Sci. 2024;65(7):6143.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The purpose of this study was to investigate whether Hippo pathway inhibition using a Lats kinase inhibitor (LKI) is sufficient to induce regeneration of the retinal pigment epithelium (RPE) in in vitro and in vivo models of RPE injury.

Methods : An in vitro wound healing assay was performed on RPE monolayers to assess RPE wound closure and RPE proliferation with TDI-011536, a novel LKI, or vehicle. Wound closure was quantified as the percentage change in wound area over time. RPE proliferation was quantified as the percentage of 5-ethynyl-2’-deoxyuridine positive (EdU+) cells in 800 µm2 regions at varying distances from the site of the wound 96 hours after wound induction. To assess the effect of LKI on RPE in vivo, laser injury was induced in Dutch belted rabbits with laser photocoagulation. Following laser, animals received intravitreal TDI-011536 or vehicle. Fundus photography and optical coherence tomography (OCT) was performed after laser as well as at 1- and 4-week time points. Following imaging, immunohistochemistry (IHC) was performed to characterize the effect of LKI on histology.

Results : In vitro RPE monolayers demonstrated increased wound healingwith TDI-011536 (n=28 regions) compared to control (n=30 regions) at 24 hours (19.5±6.3 v. 12.7±8.5; P=0.001), 48 hours (52.4±9.5 v. 34.7±11.8; P<0.0001), 72 hours (81.9±8.0 v. 56.7±13.4; P<0.0001), and 96 hours (88.8±7.13 v. 71.1±14.2; P<0.0001). RPE monolayers showed increased cell proliferation with TDI-011536 (n=39 regions) compared to control (n=45 regions) in scratch regions (43.1±17.8 v. 32.9±19.0; P=0.01) and proximal regions (13.3±13.1 v. 3.9±4.7; P<0.0001) but not distal regions (3.3±3.2 v. 2.1±3.1; P=0.09) (Figure 1A-D). Four weeks after laser injury in an in vivo model of retinal degeneration, eyes treated with TDI-011536 (n=8 eyes) demonstrated hyperpigmentation of laser spots on fundus photos (n=8 eyes). On OCT, TDI-011536-treated eyes showed thickening of the RPE with increased shadowing underlying the laser spots. On IHC, TDI-011536-treated eyes demonstrated hypertrophy of the RPE layer at sites of laser damage (Figure 2A-B).

Conclusions : TDI-011536 induced RPE wound healing in an in vitro model of RPE injury. In addition, intravitreal LKI demonstrated changes consistent with RPE regeneration on fundus photos, OCT, and IHC in an in vivo model of retinal damage. These findings prompt further study of LKIs to treat degenerative retinal disorders.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

 

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×